Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Pirfenidone
Related studies linked through entity extraction aliases.
Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
- Status
- COMPLETED
- Phase
- PHASE2
Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
- Status
- COMPLETED
- Phase
- PHASE1
Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer
- Status
- COMPLETED
- Phase
- NA
Pirfenidone to Treat Hypertrophic Cardiomyopathy
- Status
- COMPLETED
- Phase
- PHASE2
Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
- Status
- COMPLETED
- Phase
- PHASE2
Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome
- Status
- COMPLETED
- Phase
- PHASE2